Related Articles
Blood‑based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer‑risk stratification
No association of the MTHFR gene A1298C polymorphism with the risk of prostate cancer: A meta-analysis
Meta‑analysis of the association between aldose reductase gene (CA)n microsatellite variants and risk of diabetic retinopathy
Overexpression levels of cripto‑1 predict poor prognosis in patients with prostate cancer following radical prostatectomy
Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia